Immunotherapy: Open Access

Immunotherapy: Open Access
Open Access

ISSN: 2471-9552

Commentary - (2016) Volume 2, Issue 3

Bispecific Antibody Goes to Hybrid

Aifen Li1,2, Li Li1,2, Qing Li1,2 and Zhong Wang1,2*
1School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China
2Center for Cellular and Structural Biology, Sun Yat-sen University, Guangzhou, China
*Corresponding Author: Zhong Wang, Center for Cellular and Structural Biology, Sun Yat-sen University, Guangzhou, China, Tel: 020-39943453 Email:

Abstract